William C Little Selected Research

William C Little Research Topics

18	Heart Failure 09/2018 - 04/2002
6	Diastolic Heart Failure 04/2014 - 04/2005
5	Myocardial Infarction 09/2018 - 11/2003
5	Coronary Artery Disease (Coronary Atherosclerosis) 09/2018 - 07/2005
5	Ischemia 04/2015 - 08/2006
5	Cardiovascular Diseases (Cardiovascular Disease) 08/2013 - 08/2005
5	Thrombosis (Thrombus) 06/2010 - 02/2008
4	Hypertension (High Blood Pressure) 01/2012 - 07/2005
3	Myocardial Ischemia (Ischemic Heart Diseases) 04/2015 - 11/2003
2	Breast Neoplasms (Breast Cancer) 08/2013 - 01/2010
2	Neoplasms (Cancer) 08/2013 - 01/2010
2	Lymphoma (Lymphomas) 08/2013 - 01/2010
2	Leukemia 08/2013 - 01/2010
2	Acute Coronary Syndrome 07/2013 - 12/2006
2	Alcoholic Cardiomyopathy 07/2010 - 07/2006
2	Death (Near-Death Experience) 02/2009 - 11/2003
2	Left Ventricular Dysfunction 08/2006 - 03/2005
2	Anemia 04/2004 - 09/2003
1	Cardiomyopathies (Cardiomyopathy) 09/2018
1	Chest Pain (Chest Pains) 07/2013
1	Pulmonary Hypertension 05/2012
1	Atrial Fibrillation 01/2012
1	Tachycardia (Tachyarrhythmias) 08/2011
1	Pulmonary Edema 02/2011
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 09/2009
1	AIDS-Related Complex (ARC) 09/2008
1	ST Elevation Myocardial Infarction 05/2008
1	Non-ST Elevated Myocardial Infarction 12/2006
1	Unstable Angina 12/2006
1	Aortic Valve Stenosis (Aortic Stenosis) 11/2005
1	Systolic Heart Failure 05/2005
1	Infarction (Infarctions) 02/2005
1	Cicatrix (Scar) 02/2005
1	Chronic Kidney Failure (Chronic Renal Failure) 09/2003
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 09/2003
1	Hypoxia (Hypoxemia) 09/2003

6	Dobutamine FDA LinkGeneric 04/2015 - 11/2003
5	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2015 - 04/2004
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2015 - 07/2005
3	Adrenergic Agents (Adrenergic Drugs)IBA 09/2012 - 02/2011
3	Simendan (Levosimendan)IBA 08/2011 - 02/2005
2	pro-brain natriuretic peptide (1-76)IBA 09/2018 - 10/2015
2	GadoliniumIBA 04/2015 - 08/2013
2	AnthracyclinesIBA 08/2013 - 01/2010
2	ElementsIBA 05/2012 - 03/2005
2	MetalsIBA 02/2009 - 02/2007
1	C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA 01/2016
1	Oxygen (Dioxygen)IBA 04/2015
1	SodiumIBA 04/2014
1	sitaxsentanIBA 04/2014
1	Endothelins (Endothelin)IBA 04/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2013
1	Troponin IIBA 08/2013
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 05/2012
1	Enalapril FDA LinkGeneric 07/2010
1	beta Adrenergic ReceptorsIBA 07/2010
1	Irbesartan FDA LinkGeneric 03/2010
1	Troponin CIBA 09/2009
1	Eptifibatide (Integrilin)FDA Link 12/2006
1	Abciximab (ReoPro)FDA Link 12/2006
1	omega-Chloroacetophenone (Mace)IBA 12/2006
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 08/2006
1	Losartan (Cozaar)FDA LinkGeneric 08/2006
1	Angiotensin IIIBA 07/2006
1	Type 1 Angiotensin ReceptorIBA 07/2006
1	CreatinineIBA 07/2005
1	Glucose (Dextrose)FDA LinkGeneric 04/2005
1	alagebriumIBA 04/2005
1	ChloridesIBA 04/2005
1	Hormones (Hormone)IBA 09/2003
1	Erythropoietin FDA Link 09/2003

15	Therapeutics 09/2018 - 09/2003
6	Stents 06/2010 - 02/2007
2	Drug Therapy (Chemotherapy) 08/2013 - 09/2003
2	Drug-Eluting Stents 09/2008 - 02/2007
2	Percutaneous Coronary Intervention 05/2008 - 08/2005
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 09/2018
1	Cardiac Resynchronization Therapy 10/2015
1	Length of Stay 04/2014
1	Patient Readmission 07/2013
1	Contraindications 04/2002